EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C2H4O2.C66H83N17O13 |
| Net Charge | 0 |
| Average Mass | 1382.548 |
| Monoisotopic Mass | 1381.65676 |
| SMILES | CC(=O)O.CC(C)C[C@H](NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc2ccccc12)NC(=O)[C@H](Cc1cncn1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O |
| InChI | InChI=1S/C66H83N17O13.C2H4O2/c1-36(2)25-48(58(89)76-47(13-7-23-71-66(68)69)65(96)83-24-8-14-54(83)64(95)73-33-55(67)86)77-60(91)50(28-38-15-18-39-9-3-4-10-40(39)26-38)78-59(90)49(27-37-16-19-43(85)20-17-37)79-63(94)53(34-84)82-61(92)51(29-41-31-72-45-12-6-5-11-44(41)45)80-62(93)52(30-42-32-70-35-74-42)81-57(88)46-21-22-56(87)75-46;1-2(3)4/h3-6,9-12,15-20,26,31-32,35-36,46-54,72,84-85H,7-8,13-14,21-25,27-30,33-34H2,1-2H3,(H2,67,86)(H,70,74)(H,73,95)(H,75,87)(H,76,89)(H,77,91)(H,78,90)(H,79,94)(H,80,93)(H,81,88)(H,82,92)(H4,68,69,71);1H3,(H,3,4)/t46-,47-,48-,49-,50+,51-,52-,53-,54-;/m0./s1 |
| InChIKey | GUJYDLHACHDKAJ-CFWZQLQRSA-N |
| Roles Classification |
|---|
| Biological Role: | gonadotropin releasing hormone agonist Any drug which binds to gonadotropin-releasing hormone receptors and triggers a response. |
| Applications: | anti-estrogen A drug which acts to reduce estrogenic activity in the body, either by reducing the amount of estrogen or by reducing the activity of whatever estrogen is present. gonadotropin releasing hormone agonist Any drug which binds to gonadotropin-releasing hormone receptors and triggers a response. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| nafarelin acetate (CHEBI:167202) has part nafarelin (CHEBI:7445) |
| nafarelin acetate (CHEBI:167202) has role anti-estrogen (CHEBI:50751) |
| nafarelin acetate (CHEBI:167202) has role gonadotropin releasing hormone agonist (CHEBI:63533) |
| nafarelin acetate (CHEBI:167202) is a acetate salt (CHEBI:59230) |
| Incoming Relation(s) |
| nafarelin acetate hydrate (CHEBI:7446) has part nafarelin acetate (CHEBI:167202) |
| IUPAC Name |
|---|
| (2S)-N-(2-amino-2-oxoethyl)-1-{(2S,5S,8R,11S,14S,17S,20S)-2-(3-carbamimidamidopropyl)-11-(4-hydroxybenzyl)-14-(hydroxymethyl)-20-(1H-imidazol-4-ylmethyl)-17-(1H-indol-3-ylmethyl)-5-(2-methylpropyl)-8-(naphthalen-2-ylmethyl)-4,7,10,13,16,19,22-heptaoxo-22-[(2S)-5-oxopyrrolidin-2-yl]-3,6,9,12,15,18,21-heptaazadocosan-1-oyl}pyrrolidine-2-carboxamide acetate |
| Synonyms | Source |
|---|---|
| (6-D-(2-naphthyl)alanine)LHRH acetate | ChemIDplus |
| nafarelin acetate (anhydrous) | ChEBI |
| nafarelin acetate anhydrous | ChemIDplus |
| Registry Numbers | Sources |
|---|---|
| CAS:76932-60-0 | ChemIDplus |
| Citations |
|---|